Amgen (AMGN): FY24 Q4 earnings call, Feb 4, 2025
No Kalshi or Polymarket word markets were listed for Amgen’s Feb 4, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
1 match for “Patent”; 1 quoted, at least 25 words apart.
…This growth will more than offset declines due to the upcoming denosumab patent expiration as well as continued price declines across our portfolio in 2025.…
Agents: this page as TSV at /api/v1/appearances/amgen:2025-02-04:earnings_call · words: /api/v1/brief?appearance=amgen:2025-02-04:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP